Abiraterone - Cancer Science

Relevant Publications

Tracking protein-protein interactions by NMR: conformational selection in human steroidogenic cytochrome P450 CYP17A1 induced by cytochrome .

Issue Release: 2024

An in vitro testicular organoid model for the study of testis morphogenesis, somatic cell maturation, endocrine function, and toxicological assessment of endocrine disruptors.

Issue Release: 2024

Docetaxel versus androgen receptor signaling inhibitor (ARSI) against chemo-naïve castration-resistant prostate cancer (CRPC): propensity score matched analysis in real world.

Issue Release: 2024

The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in second-line treatment: a systematic review and bayesian network meta-analysis.

Issue Release: 2024

Controversies in prostate cancer management: Consensus recommendations from experts in northern Spain.

Issue Release: 2024

Intra-individual Dose Escalation of Abiraterone According to Its Plasma Exposure in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer: Results of the OPTIMABI Trial.

Issue Release: 2024

Abiraterone, Olaparib, or Abiraterone + Olaparib in First-line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway).

Issue Release: 2024

Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma.

Issue Release: 2024

Independent association between prostate-specific antigen nadir and PSA progression-free survival in first-line abiraterone acetate treatment in castration-resistant prostate cancer patients: a pilot study.

Issue Release: 2024

Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review.

Issue Release: 2024

Evaluating first-line therapeutic strategies for metastatic castration-resistant prostate cancer: a comprehensive network meta-analysis and systematic review.

Issue Release: 2024

Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial.

Issue Release: 2024

Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial.

Issue Release: 2024

Effects of metformin and silodosin as supplementary treatments to abiraterone on human telomerase reverse transcriptase (hTERT) level in metastatic castration-resistant prostate cancer (mCRPC) cells: An in vitro study.

Issue Release: 2024

Combination of miR-99b-5p and Enzalutamide or Abiraterone Synergizes the Suppression of EMT-Mediated Metastasis in Prostate Cancer.

Issue Release: 2024

Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis.

Issue Release: 2024

Exploring optimal drug targets through subtractive proteomics analysis and pangenomic insights for tailored drug design in tuberculosis.

Issue Release: 2024

Comparative effectiveness of first-line systemic treatments for metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.

Issue Release: 2024

Comparative effectiveness of multiple androgen receptor signaling inhibitor medicines with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: a study in the real world.

Issue Release: 2024

The rates of septicemia in older adults with prostate cancer treated with abiraterone or enzalutamide: A population-based study.

Issue Release: 2024

How Do Endocrinologists Manage Long-Term Cancer Effects?

How Does the NTP Conduct Its Research?

What Are the Main Types of Methodologies in Cancer Research?

How Do Environmental and Lifestyle Factors Influence Predictions?

How Are Metabolic Pathways Studied in Cancer Research?

What Are the Key Resources for Cancer Patients?

What Are the Long-Term Effects of Radiation Therapy?

What is Dronabinol?

How Does Pysurvival Work?

What Are the Benefits of CGP?

Abiraterone - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics